| IL10 |
P22301
|
interleukin 10
|
|
5.9E-03 |
0.281 |
0.923 |
| CCL2 |
P13500
|
C-C motif chemokine ligand 2
|
Signaling
|
0.61 |
0.321 |
0.962 |
| ACTB |
P60709
|
actin beta
|
Cellular structure
|
0.99 |
0.325 |
0.923 |
| HIF1A |
Q16665
|
hypoxia inducible factor 1 subunit alpha
|
Transcription factor
|
0.98 |
0.327 |
0.923 |
| APOE |
P02649
|
apolipoprotein E
|
|
1.9E-03 |
0.338 |
0.962 |
| CD34 |
P28906
|
CD34 molecule
|
|
5.0E-06 |
0.368 |
0.808 |
| JAK2 |
O60674
|
Janus kinase 2
|
Kinase
|
0.65 |
0.385 |
0.885 |
| ALK |
Q9UM73
|
ALK receptor tyrosine kinase
|
Kinase
|
3.2E-06 |
0.396 |
0.846 |
| KMT2A |
Q03164
|
lysine methyltransferase 2A
|
|
1.00 |
0.410 |
0.885 |
| CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
| TNFRSF11B |
O00300
|
TNF receptor superfamily member 11b
|
|
0.16 |
0.422 |
0.808 |
| BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
| ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
| LGALS1 |
P09382
|
galectin 1
|
Signaling
|
4.5E-03 |
0.435 |
0.846 |
| LDLR |
P01130
|
low density lipoprotein receptor
|
|
9.8E-24 |
0.449 |
0.885 |
| TNFSF11 |
O14788
|
TNF superfamily member 11
|
Signaling
|
4.9E-03 |
0.453 |
0.846 |
| TEK |
Q02763
|
TEK receptor tyrosine kinase
|
Kinase
|
1.00 |
0.462 |
0.692 |
| SUB1 |
P53999
|
SUB1 regulator of transcription
|
|
0.89 |
0.465 |
0.846 |
| NOX4 |
Q9NPH5
|
NADPH oxidase 4
|
Enzyme
|
5.8E-20 |
0.471 |
0.885 |
| IL18R1 |
Q13478
|
interleukin 18 receptor 1
|
Receptor
|
8.6E-06 |
0.473 |
0.808 |
| EBI3 |
Q14213
|
Epstein-Barr virus induced 3
|
Signaling
|
0.11 |
0.474 |
0.808 |
| IL11 |
P20809
|
interleukin 11
|
|
3.2E-04 |
0.481 |
0.808 |
| PCSK9 |
Q8NBP7
|
proprotein convertase subtilisin/kexin type 9
|
Enzyme
|
2.7E-17 |
0.482 |
0.808 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| MYB |
P10242
|
MYB proto-oncogene, transcription factor
|
|
0.82 |
0.490 |
0.692 |